BusinessCynapsus Therapeutics Announces Successful Completion of Bioavailability and Pharmacokinetic Study and Provides Update on European Clinical PlansBy Nasdaq OMXDec 10, 2015, 9:11 PM UTC
BusinessOhr Pharmaceutical Reports Fiscal Year 2015 Financial and Business ResultsBy Nasdaq OMXDec 10, 2015, 9:02 PM UTC
BusinessUCHealth Eye Center Restores Limited Sight to Blind Patient with Region's First Bionic Eye SurgeryBy Nasdaq OMXDec 10, 2015, 2:12 PM UTC
BusinessImmunomedics Reports Continuing Positive Results With Sacituzumab Govitecan in Heavily Pre-Treated Metastatic Triple-Negative Breast Cancer PatientsBy Nasdaq OMXDec 10, 2015, 1:31 PM UTC
BusinessOryzon Genomics Announces Listing on Madrid Stock ExchangeBy Nasdaq OMXDec 10, 2015, 1:16 PM UTC
BusinessVitae Pharmaceuticals Opens Phase 2a Proof-of-Concept Trial of VTP-38543 in Atopic Dermatitis PatientsBy Nasdaq OMXDec 10, 2015, 12:31 PM UTC
BusinessZIOPHARM Announces Presentation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With Locally Advanced or Metastatic Breast Cancer at 2015 SABCSBy Nasdaq OMXDec 10, 2015, 12:01 PM UTC
BusinessSummit Therapeutics to Participate in the JMP Securities DMD ForumBy Nasdaq OMXDec 10, 2015, 12:01 PM UTC
